Drug intelligence / Profile preview

iridina

Development stage
Unknown
Lead developer
Montefarmaco
Modality
Classical Binding Small Molecules → Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Ophthalmic
01

Overview

Iridina is a brand of ophthalmic products primarily marketed for the relief of eye irritation, redness, burning, excessive tearing, and sensitivity to light. The most common formulation is Iridina Due®, which contains naphazoline nitrate or naphazoline hydrochloride as its active ingredient—a sympathomimetic vasoconstrictor that acts on alpha-adrenergic receptors in ocular arterioles to reduce congestion and redness[1][5][6]. Some variants (such as "Iridina Antistaminico") also contain tonzilamine hydrochloride (an antihistamine) for allergic conjunctivitis[4][8]. Other formulations under the Iridina name include lubricating drops with sodium hyaluronate for dry eyes[7][9]. The primary mechanism of action is vasoconstriction via alpha-adrenergic receptor agonism; antihistaminic action may be present in combination products.

Brand names
IridinaIridina DueIridina AntistaminicoIridina Lubricating Drops
02

Targets

ADRA1A (α1A)ADRA2A (α2A)

Beyond the preview

Go deeper on iridina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iridina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call